Companies: 10,795·Total market cap: $144.5T
Immunovant, Inc.

Immunovant, Inc.

IMVTNASDAQHealthcare● Active
$30.80
$-0.31(-1.00%)
Market Cap$6.3B
P/E Ratio
52W High$36.285
52W Low$14.32
Overview

Immunovant, Inc. (IMVT) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · IMVT · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2026-032025-032024-032023-032022-03
Operating Activities
Net Income($0.51B)($0.41B)($0.26B)($0.21B)($0.16B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.06B$0.05B$0.04B$0.03B$0.03B
Change in Working Capital$0.04B($0.01B)$0.00B($0.01B)$0.02B
Net Cash from Operations($0.41B)($0.38B)($0.21B)($0.19B)($0.11B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.60B$0.45B$0.47B$0.07B$0.20B
Free Cash Flow
Free Cash Flow($0.41B)($0.38B)($0.21B)($0.19B)($0.11B)
FCF Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more Immunovant, Inc. data

About Immunovant, Inc. (IMVT) Cash Flow Statement

Immunovant, Inc. generated operating cash flow of ($0.41B) and free cash flow of ($0.41B) for 2026 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

IMVT · 4 questions

Immunovant, Inc. generated free cash flow of ($0.41B) for 2026, down 8.1% year-over-year.

IMVT free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10